Astellas and Apellis are competing for market share in the U.S. for their geographic atrophy (GA) treatments, Izervay and Syfovre. […]
The pharmaceutical industry is highly competitive, which has led to a big increase in healthcare advertising, with spending expected to
Earlier this year, EyePoint Pharmaceuticals faced doubts about its drug-device combo, Duravyu, after it failed in a study for nonproliferative
Here’s a simplified version of the text: There’s a rare heart condition known as transthyretin amyloidosis cardiomyopathy that has caught
In the pharmaceutical world, there’s a big competition to create the best obesity drugs, currently dominated by Novo Nordisk and
Here’s a simplified summary of the regulatory updates for various pharmaceutical products: 1. **Pfizer’s Elrexfio**: Recommended in England for multiple
Thorsten Stafforst recalls being discouraged from pursuing his research. In the early 2010s, scientists were excited about CRISPR, a tool
At a conference in New England, Rohan Simon, an associate director at the UAE’s first contract research organization, discussed the
Here’s a simplified summary of the recent news from Biogen, Novartis, Resalis Therapeutics, and Moderna: **Biogen**: The biotech company has
The FDA has given special status to a new treatment called MDL-101 by Modalis Therapeutics for a rare muscle disorder
